QualityStocksNewsBreaks Archives - Page 400 of 1386

ThursdayMay 05, 2022 11:43 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Participate in Groundbreaking Study with Trokie and Radicle Science

InMed Pharmaceuticals (NASDAQ: INM) is a leader in the research, development, manufacturing and commercialization of rare cannabinoids. The company today announced that its subsidiary, BayMedica, will be providing rare cannabinoids for use in Radicle Science Inc.’s Radicle Energy rare cannabinoid study to assess the effects of delta-9 (“d-9”) dominant tetrahydrocannabivarin (“THCV”) on energy, focus/attention, appetite and weight/BMI. According to the update, BayMedia will be supplying its highly pure d-9 dominant THCV, formulated into a proprietary lozenge manufactured by Trokie. “We are excited to be part of this groundbreaking study with Trokie and Radicle Science in advance of our commercial launch…

WednesdayMay 04, 2022 3:04 pm

QualityStocksNewsBreaks – Sugarmade Inc. (SGMD) Executes on Collaborative Cannabis Cultivation Model

Sugarmade (OTC: SGMD), an emerging company in the licensed cannabis sector, today announced its first transaction relative to its collaborative cannabis cultivation strategy via a definitive and executed contract with Cannabis Global Inc. (OTC: CBGL). Under the agreement, Sugarmade, via partner licensed and permitted Lake County, California, cannabis cultivators, will produce approximately 25,000 pounds of “Fresh Frozen” cannabis, which Cannabis Global will use in its product lines and distribute to the California marketplace. “As we recently announced to our shareholders, we see a strong business model of utilizing now idle resources of other California cultivators who have decided they can…

WednesdayMay 04, 2022 2:54 pm

QualityStocksNewsBreaks – Delic Holdings Corp.’s (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Ketamine Wellness Centers Now Offer NAD+ Infusion Therapy

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, and its Ketamine Wellness Centers (“KWC”) are now offering NAD+ infusion therapy at six clinic locations. KWC is the largest ketamine therapy provider in the country to offer the therapy, which is administered intravenously or intramuscularly. According to the company, the treatment can boost natural energy stores and immunity, along with brain and DNA function as well as cell communication; the treatment can also facilitate the healing chronic conditions such as depression, PTSD and anxiety. The treatment will be available at…

WednesdayMay 04, 2022 2:47 pm

QualityStocksNewsBreaks – Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) (FSE: 7CR) Applies for Gaming Related Supplier Approval for Ontario, Canada

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FSE: 7CR) is a propriety software-as-a-service (“SaaS”) technology company delivering mobile first live dealer technology (VegasLounge(TM)) to online gaming operators globally. The company today announced that it has applied for a Gaming Related Supplier - Manufactures License with the Alcohol and Gaming Commission of Ontario (the “AGCO”). According to the update, the license will enable Playgon to supply AGCO approved operators with its live dealer tables from its state-of-the-art studio in Las Vegas, Nevada. “Ontario is now a key regulated market we wish to service with our mobile first live dealer technology,” said Darcy…

WednesdayMay 04, 2022 2:39 pm

QualityStocksNewsBreaks – Home Bistro Inc. (HBIS) Announces New Interview with Stock Investor Daily

Home Bistro (OTC: HBIS) is a leading online meal delivery platform that offers celebrity chef-inspired, gourmet and lifestyle ready-made meals. The company today announced the publishing of a recent interview with Stock Investor Daily featuring Vegan + Sustainable Celebrity Chef Priyanka Naik and Home Bistro’s Zalmi Duchman. Naik, a self-taught Indian vegan chef, Food Network champion, Quibi Dishmantled Winner, TV host, and author, and Duchman, Home Bistro’s CEO, join the interview to discuss their new partnership, exciting meal development and outlook for the company’s business. To view the full press release, visit https://ibn.fm/eIwuZ About Home Bistro Inc. Home Bistro is…

WednesdayMay 04, 2022 2:31 pm

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Robot Roadshow Takes the Stage in Columbus, Ohio

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, recently announced that its Robot Roadshow will land at the Ohio Hotel & Lodging Association (“OHLA”) meeting taking place at the Marriott Columbus OSU in Columbus, Ohio, from 10:00 a.m. to 2:00 p.m. ET today. The Robot Roadshow is an engaging experiential event designed to grab attention, forge direct connections with potential clients, and strike up conversations in a compelling fashion. The announcement reads, “The Robot Roadshow has made 37 landings in 14 states and Washington, D.C., to date. Knightscope’s crime-fighting robots tour the…

WednesdayMay 04, 2022 2:17 pm

QualityStocksNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Announces Partnership with IBN for Corporate Communications Needs

Golden Matrix Group (NASDAQ: GMGI), an established gaming technology company that develops and owns online gaming IP and builds turnkey online casino solutions for gaming operators, has selected InvestorBrandNetwork (“IBN”) for its corporate communications needs. IBN is a multifaceted financial news and publishing company that offers communications expertise and solutions for private and public entities. According to the announcement, GMGI is developing fully operational, turnkey online casino solutions along with configurable and scalable gaming platforms for international customers. The company focuses user acquisition, engagement, retention and monetization. Golden Matrix also offers white-label gaming platforms that compatible with all major operating…

WednesdayMay 04, 2022 1:59 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters First UST Early Access Manufacturing Agreement

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty services to the worldwide biopharmaceuticals, cosmetics, nutraceuticals, agrochem, and food & beverage industries, has signed its inaugural nanoemulsions development and manufacturing agreement under its recently released Ultra Shear Technology(TM) (“UST”) early-access program. The agreement, signed with Safer Medical of Montana (“SMM”), covers formulation, pilot batches and commercial production for a CBD topical spray designed to reduce pain. According to the announcement, all products discussed in the contract will include high-quality nanoemulsions of oils in water produced by using PBI's revolutionary…

WednesdayMay 04, 2022 1:45 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Launches New Skincare Line Ahead of Luxury Meets Cannabis Conference

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced the launch of a new skincare line under its brand, MIND Naturals (“Mind”), ahead of the Luxury Meets Cannabis Conference (“LMCC”) in New York City. Mind is inspired by its Colombian roots and leverages superfruits and nutrients native to Colombia for its new non-CBD line of skincare products. “This is a very exciting launch from MIND Naturals and Flora - the U.S. skincare market alone presents a unique opportunity for growing all-natural skincare brands, with annual revenue of approximately $17.6 billion,” said Flora…

WednesdayMay 04, 2022 1:23 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Transition from Pure-Play Pharma R&D Firm Featured in Research Report

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, was featured in a report published by Edison Group, a leading research and investor relations consultancy. The piece details InMed Pharmaceuticals and its continued “transition from a pure-play pharma R&D firm to one also benefiting from commercial sales into the health and wellness market. Product launches of high-value, rare cannabinoids into this market should provide the majority of its revenue in the near future,” the report reads. “INM also made notable advances in its pharmaceutical drug development programs, including its ongoing 755-201-EB Phase II…

Site Search

Company Search

Category: QualityStocksNewsBreaks